Clozapine binds preferentially to cortical D1-like dopamine receptors in the primate brain:: a PET study

Rationale: The D-1-like dopamine receptors have been suggested to play a role in the pathophysiology and treatment of schizophrenia. Previous positron emission tomography studies have demonstrated that the atypical antipsychotic clozapine occupies D-1-like dopamine receptors in the striatum in clozapine-treated patients. Objectives: The aim of the present study was to compare striatal and cortical D-1-like dopamine receptor occupancy by clozapine in the primate brain. Methods: Three monkeys were each examined three times at the same day with the radioligand (+)-[C-11]NNC 112. The first measurement was at baseline conditions, the second after 1.5 mg/kg and the third after 6 mg/kg clozapine IV. To compare regional levels of nonspecific binding in brain regions, an additional monkey was examined using the inactive enantiomer (-)-[C-11] NNC 112. Receptor occupancy was calculated using both the equilibrium - ratio analysis and the simplified reference tissue model. Results: After 1.5 mg/kg the D-1-like dopamine receptor occupancy ranged from 30 to 38% in the striatum, whereas the range was 51 to 57% in the frontal cortex. After 6.0 mg/kg the occupancy was 53 to 64% in the striatum and 63 to 83% in the frontal cortex. The differences between striatal and cortical D-1-like receptor occupancy were between 12 and 25%. The study with (-)-[C-11] NNC 112 did not show regional differences in nonspecific binding that might explain the regional differences in occupancy. Conclusions: The higher D-1-like dopamine receptor occupancy in the frontal cortex may reflect a different distribution of the D1 and D5 dopamine receptor subtypes among brain regions and different affinity of clozapine for the two subtypes. The finding supports the suggestion that binding to D-1-like dopamine receptors may explain clozapine's atypical drug actions.